Microbiota, a New Playground for the Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Diseases

Area of Science:

• Cardiovascular Health
• Microbiology
• Nutrition Science

Background:

• Cardiovascular diseases are linked to gut microbiota imbalances and low-level inflammation.
• Omega-3 polyunsaturated fatty acids (PUFAs) are known for cardioprotective effects.
• The role of gut microbiota in cardiovascular pathologies is increasingly recognized.

Purpose of the Study:

• To review the impact of omega-3 PUFAs on gut microbiota composition and function.
• To explore the mechanisms by which omega-3 PUFAs influence cardiovascular health via the gut microbiota.
• To summarize the potential of omega-3 PUFAs in mitigating microbiota-associated cardiovascular risks.

Main Methods:

• Literature review of studies investigating omega-3 PUFAs, gut microbiota, and cardiovascular health.
• Analysis of proposed mechanisms, including effects on specific bacterial populations and inflammatory markers.
• Synthesis of evidence on the interplay between dietary PUFAs and intestinal health in the context of cardiac conditions.

Main Results:

• Omega-3 PUFAs can modulate gut microbiota, reducing trimethylamine (TMA)-producing bacteria.
• They promote the growth of butyrate-producing bacteria, known for anti-inflammatory properties.
• Omega-3 PUFAs may decrease pro-inflammatory cytokine production and enhance intestinal barrier integrity.

Conclusions:

• Dietary omega-3 PUFAs show promise in restoring gut microbiota balance, thereby benefiting cardiovascular health.
• Modulating the gut microbiota through omega-3 PUFAs offers a potential strategy to reduce cardiovascular disease risk and severity.
• Further research into the precise mechanisms is warranted to optimize therapeutic applications.